复星医药：关于控股子公司药品获注册批准的公告

Core Points - Recently, Shanghai Fosun Pharmaceutical (Group) Co., Ltd. announced that its subsidiary, Jinzhou Aohong Pharmaceutical Co., Ltd., received approval from the National Medical Products Administration for the drug registration application of Famotidine injection [1] Group 1 - The approval of Famotidine injection marks a significant milestone for the company in expanding its pharmaceutical product offerings [1]